Sign in

CIK 0001388320

  • Non-accelerated filer
  • Smaller reporting company

Actinium Pharmaceuticals, Inc.

Sign in to watch
Ticker
ATNM
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
880378336
Phone
+1 646-677-3870
Business address
100 PARK AVE., 23RD FLOOR, NEW YORK, NY, 10017
Former names
Cactus Ventures, Inc.
  1. 4 Open-market sale 10% owner sold 9,468 shares at an average $1.72 ($16,287)
  2. 4 Open-market sale 10% owner sold 3,100 shares at an average $1.80 ($5,581)
  3. 4 Open-market sale 10% owner sold 21,990 shares at $1.80 ($39,582)
  4. 4 Open-market sale 10% owner sold 20,840 shares at an average $1.81 ($37,762)
  5. 4 Open-market sale 10% owner sold 148,100 shares at an average $1.81 ($268,436)
  6. 4 Open-market sale 10% owner sold 33,619 shares at $1.90 ($63,876)
  7. 4 Open-market sale 10% owner sold 17,790 shares at an average $2.01 ($35,716)
  8. 4 Open-market sale 10% owner sold 169,450 shares at an average $1.97 ($333,385)
  9. 4 Open-market sale 10% owner sold 40,068 shares at an average $1.92 ($77,061)
  10. 4 Open-market sale 10% owner sold 36,400 shares at an average $1.90 ($69,236)
  11. 4 Open-market sale 10% owner sold 52,577 shares at an average $2.04 ($107,265)
  12. 4 Open-market sale 10% owner sold 196,497 shares at an average $2.03 ($398,919)
  13. 4 Open-market buy Director bought 5,000 shares at $2.00 ($10,000)
  14. 4 Open-market buy CEO and Interim CFO bought 10,000 shares at an average $2.02 ($20,180)
  15. 4 Open-market buy Director bought 15,000 shares at an average $1.99 ($29,900)
  16. 4 Derivatives Options or other derivatives
  17. 4 Open-market buy Director bought 2,500 shares at $2.01 ($5,025)
  18. 4 Open-market buy Director bought 3,000 shares at $2.02 ($6,060)
  19. 4 Returned to the company President, CEO and Interim CFO returned 120,501 shares (to the company)
  20. 4 Returned to the company COO and Chief Medical Officer returned 2,380 shares (to the company)

Page 6 of 8 · 146 filings